These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 33858328)

  • 1. A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department.
    Wiercigroch D; Hoyeck P; Sheikh H; Hulme J
    BMC Emerg Med; 2021 Apr; 21(1):48. PubMed ID: 33858328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and Facilitators to Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine.
    Hawk KF; D'Onofrio G; Chawarski MC; O'Connor PG; Cowan E; Lyons MS; Richardson L; Rothman RE; Whiteside LK; Owens PH; Martel SH; Coupet E; Pantalon M; Curry L; Fiellin DA; Edelman EJ
    JAMA Netw Open; 2020 May; 3(5):e204561. PubMed ID: 32391893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing System and Clinician Barriers to Emergency Department-initiated Buprenorphine: An Evaluation of Post-intervention Physician Outcomes.
    Mahal JJ; Bijur P; Sloma A; Starrels J; Lu T
    West J Emerg Med; 2024 May; 25(3):303-311. PubMed ID: 38801034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of buprenorphine initiation and warm handoff protocols in emergency departments: A qualitative study of Pennsylvania hospitals.
    Patel E; Solomon K; Saleem H; Saloner B; Pugh T; Hulsey E; Leontsini E
    J Subst Abuse Treat; 2022 May; 136():108658. PubMed ID: 34774397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation of Buprenorphine in the Emergency Department: A Survey of Emergency Clinicians.
    Barkley A; Lander L; Dilcher B; Tuscano M
    West J Emerg Med; 2024 Jul; 25(4):470-476. PubMed ID: 39028232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and facilitators associated with establishment of emergency department-initiated buprenorphine for opioid use disorder in rural Maine.
    Rosenberg NK; Hill AB; Johnsky L; Wiegn D; Merchant RC
    J Rural Health; 2022 Jun; 38(3):612-619. PubMed ID: 34468047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variability in opioid use disorder clinical presentations and treatment in the emergency department: A mixed-methods study.
    Faude S; Delgado MK; Perrone J; McFadden R; Xiong RA; O'Donnell N; Wood C; Solomon G; Lowenstein M
    Am J Emerg Med; 2023 Apr; 66():53-60. PubMed ID: 36706482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver.
    Lanham HJ; Papac J; Olmos DI; Heydemann EL; Simonetti N; Schmidt S; Potter JS
    JAMA Netw Open; 2022 May; 5(5):e2212419. PubMed ID: 35552721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and facilitators to nurse practitioner buprenorphine prescribing for opioid use disorder in primary care settings.
    Speight C; Caiola C; Tyndall DE; Scott ES
    J Am Assoc Nurse Pract; 2023 Feb; 35(2):112-121. PubMed ID: 36512806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices.
    Andraka-Christou B; Capone MJ
    Int J Drug Policy; 2018 Apr; 54():9-17. PubMed ID: 29324253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency Department Clinicians' Attitudes Toward Opioid Use Disorder and Emergency Department-initiated Buprenorphine Treatment: A Mixed-Methods Study.
    Im DD; Chary A; Condella AL; Vongsachang H; Carlson LC; Vogel L; Martin A; Kunzler N; Weiner SG; Samuels-Kalow M
    West J Emerg Med; 2020 Feb; 21(2):261-271. PubMed ID: 32191184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond Buprenorphine: Models of Follow-up Care for Opioid Use Disorder in the Emergeny Department.
    Martin A; Butler K; Chavez T; Herring A; Wakeman S; Hayes BD; Raja A
    West J Emerg Med; 2020 Nov; 21(6):257-263. PubMed ID: 33207174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives of Clinicians and Staff at Community-Based Opioid Use Disorder Treatment Settings on Linkages With Emergency Department-Initiated Buprenorphine Programs.
    Sue KL; Chawarski M; Curry L; McNeil R; Coupet E; Schwartz RP; Wilder C; Tsui JI; Hawk KF; D'Onofrio G; O'Connor PG; Fiellin DA; Edelman EJ
    JAMA Netw Open; 2023 May; 6(5):e2312718. PubMed ID: 37163263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practical review of buprenorphine utilization for the emergency physician in the era of decreased prescribing restrictions.
    Pourmand A; Beisenova K; Shukur N; Tebo C; Mortimer N; Mazer-Amirshahi M
    Am J Emerg Med; 2021 Oct; 48():316-322. PubMed ID: 34274576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linking MATTERS: Barriers and Facilitators to Implementing Emergency Department-Initiated Buprenorphine-Naloxone in Patients with Opioid Use Disorder and Linkage to Long-Term Care.
    Sokol R; Tammaro E; Kim JY; Stopka TJ
    Subst Use Misuse; 2021; 56(7):1045-1053. PubMed ID: 33825669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).
    D'Onofrio G; Edelman EJ; Hawk KF; Pantalon MV; Chawarski MC; Owens PH; Martel SH; VanVeldhuisen P; Oden N; Murphy SM; Huntley K; O'Connor PG; Fiellin DA
    Implement Sci; 2019 May; 14(1):48. PubMed ID: 31064390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers and attitudes reported by Canadian emergency physicians regarding the initiation of buprenorphine/naloxone in the emergency department for patients with opioid use disorder.
    Savage T; Ross M
    CJEM; 2022 Jan; 24(1):44-49. PubMed ID: 34564838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary care physicians' preparedness to treat opioid use disorder in the United States: A cross-sectional survey.
    Foti K; Heyward J; Tajanlangit M; Meek K; Jones C; Kolodny A; Alexander GC
    Drug Alcohol Depend; 2021 Aug; 225():108811. PubMed ID: 34175786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians' experiences with buprenorphine: A qualitative study of motivations for becoming X waivered and barriers to and facilitators of prescribing the medication for opioid use disorder.
    McCollum CG; Eaton E; Creger T; Lee A; Gagnon K; Li L
    Drug Alcohol Depend; 2023 Mar; 244():109777. PubMed ID: 36680808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
    Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD
    Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.